Clinical Trials Logo
  1. Home
  2. Vertebral Compression Fracture
  3. NCT04835428

STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

Vertebral Compression Fracture Clinical Trial

Official title:
A Randomized, Single-Blinded, Non-Inferiority Study Comparing AGN1 Local Osteo-Enhancement Procedure (LOEP) SV Kit Treatment of Vertebral Compression Fragility Fractures to PMMA Bone Cement Treatment

Clinical Trial Summary

This is a multicenter, single-blinded, randomized controlled clinical trial evaluating the safety and efficacy of the AGN1 LOEP SV Kit for the treatment of painful vertebral compression fragility fractures (VCFs). The objective of this study is to demonstrate non-inferiority of the AGN1 LOEP SV Kit for the treatment of VCFs to standard of care vertebroplasty treatment using bipedicular injection of PMMA bone cement.

Clinical Trial Description

Four hundred and eight (408) eligible subjects at up to twenty-five (25) study sites will be randomized 1:1 for treatment using the AGN1 LOEP SV Kit (Intervention Group) or PMMA bone cement (Active Control Group). 1. Intervention Group - receives vertebral augmentation of the target VCF(s) using the AGN1 LOEP SV Kit 2. Active Control Group - receives vertebral augmentation of the target VCF(s) using either Stryker VertaPlex HV or Medtronic Kyphon HV-R. Follow-up visits will be conducted at 7 days, 28 days, 3 months, 12 months and 24 months after the procedure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04835428
Study type Interventional
Source AgNovos Healthcare, LLC
Contact Allison Gorman
Phone 2407536424
Email agorman@agnovos.com
Status Recruiting
Phase N/A
Start date May 31, 2022
Completion date December 31, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT01643395 - VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures Phase 3
Enrolling by invitation NCT05018637 - Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture Phase 2
Completed NCT03523000 - Determining the Prognostic Value of Continuous Intrathecal Infusion Phase 4
Recruiting NCT04821739 - RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures N/A
Completed NCT04135755 - The Spine Kinematics and Center of Pressure Excursion During Functional Task Vertebral Compression Fractures Subjects
Recruiting NCT05676320 - Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures N/A
Recruiting NCT04581707 - Performance and Safety of Joline® Kyphoplasty Single Balloon Catheter Allevo vs. Quattroplasty Double-Balloon Catheter Stop'n GO With BonOs® Inject Bone Cement
Completed NCT01383616 - Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures Phase 4
Recruiting NCT05912504 - Long Term Follow-up of Vertebral Compression Fracture In-patients Treated: A Retrospective Chart Review and Survey
Completed NCT06153576 - The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
Completed NCT03580434 - The Purpose of This Study is to Evaluate Safety and Performance of the V-STRUT© Transpedicular Vertebral System N/A
Suspended NCT03651804 - Radiofrequency Ablation: Treatment for Posterior Element Pain From Vertebral Compression Fractures Phase 4